Over the past decade, regulators started approving them as treatments for weight loss first as liraglutide, sold under the brand Saxenda and, more recently, in the form of semaglutide or tirzepatide, under brands like Wegovy and Zepbound
Individual experimentation often leads to personalized modifications that improve long-term adherence
Every peptide in the GLP-1 family works by binding to specific receptors on cells throughout the body
Approximately 25% of the weight lost on tirzepatide was lean mass rather than fat, and in semaglutide trials (STEP 1 DXA subset), that proportion may approach 40%
For a complete list of ingredients and safety details, refer to the Contrave medication guide
Gustatory and extragustatory functions of mammalian taste receptors